share_log

HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Lowers Price Target to $14

HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Lowers Price Target to $14

HC Wainwright & Co.維持對Ocular Therapeutix的買入,將目標股價下調至14美元
Benzinga ·  05/08 15:19

HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and lowers the price target from $16 to $14.

HC Wainwright & Co. 分析師陳毅維持Ocular Therapeutix(納斯達克股票代碼:OCUL)的買入並將目標股價從16美元下調至14美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論